As of 10:20 HKT on September 28, 2026, Hang Seng High Dividend 30 Index ETF (03466.HK) rose 0.86% to HK$18.850, tracking the Hang Seng High Dividend 30 Index.
As of 10:20 HKT on September 28, 2026, CSOP FTSE East-West Equity Select ETF (03441.HK) rose 0.82% to HK$13.560, covering HK and US stocks, board lot 100 units.
As of 09:51 HKT on September 28, 2026, CSOP Hang Seng China Enterprises Index Daily (2x) Leveraged Product (07288.HK) rose 2.27% to HK$2.794, turnover HK$2.35m.
As of 09:51 HKT on September 28, 2026, CSOP Hang Seng Index Daily (2x) Leveraged Product (07200.HK) rose 1.51% to HK$5.390, tracking the Hang Seng Index.
On September 24, 2026, the HK shares ETFs market showed a defensive tilt. Dividend and high-dividend-yield products led the gains, with Ping An of China CSI HK Dividend ETF (03070.HK) up 1.04% to top the gainers list and six of the top ten gainers being dividend-related products. On the downside, Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK) fell 5.32% to lead the losers, while biotech, 5G, copper miners, gold miners and blockchain themes all dropped no less than 2.5%. Among southbound Stock Connect ETFs, dividend products edged higher while biotech led the declines, with CSOP Hang Seng Biotech ETF (03174.HK) down 2.50% at the top of the losers.
As of 15:33 HKT on September 24, 2026, CSOP Hang Seng Biotech ETF (03174.HK) fell 2.50% to HK$3.826 on HK$7.42m turnover, tracking the Hang Seng Biotech Index.
As of 13:48 HKT on September 24, 2026, E Fund (HK) CSI Liquor Index ETF (03189.HK) fell 2.15% to HK$1.092, tracking CSI Liquor Index with board lot 100 units.
As of 13:48 HKT on September 24, 2026, CSOP Nikkei 225(03153.HK) fell 1.70% to HK$133.250, tracking the Nikkei 225 Index with a board lot of 10 units.
Samsung S&P GSCI Crude Oil ER Futures ETF (03175.HK) rose 2.00% to HK$11.750 on Sep 24 after EIA data showed a 3-million-barrel US crude build.
Bosera China Reform Hong Kong Central-SOEs High Dividend Yield Index ETF (03437.HK) rose 0.40% to HK$10.060 on Sep 24; China Shenhua approved a RMB0.98 DPS.
Ping An of China CSI HK Dividend ETF (03070.HK) rose 13.28% YTD, beating its index; its Q3 payout of HKD 1.03 per unit went ex on 24 September.
CSOP Hang Seng Biotech ETF (03174.HK) fell 2.60% to HK$3.822 on Sep 24, still up 1.70% this week; InnoCare signed a Lilly licensing deal worth up to US$3.25bn.
As of 13:27 HKT on September 24, 2026, iShares China Government Bond ETF (02829.HK) fell 0.22% to HK$63.960, with HK$3.605 billion in assets and 1.95% yield.
As of 11:40 HKT on Sept 24, 2026, E Fund (HK) FTSE AI Select Index ETF (03489.HK) fell 1.26% to HK$13.330, with HK$806 million in assets and 100 units per lot.
As of 11:39 HKT on Sept 24, 2026, CSOP FTSE HK-Korea Tech+ Index ETF (03431.HK) fell 1.15% to HK$10.360, with HK$1.269 billion in assets and 100 units per lot.
As of 11:18 HKT on Sep 24, 2026, iShares Core MSCI AC Asia ex Japan Index ETF (03010.HK) fell 0.98% to HK$91.100, with HK$37.347 billion in assets, 0.85% yield.